IVOIX | VMVIX | IVOIX / VMVIX | |
Total Expense Ratio | 0.83 | 0.19 | 437% |
Annual Report Gross Expense Ratio | 1.00 | 0.19 | 526% |
Fund Existence | 11 years | 19 years | - |
Gain YTD | 11.531 | 6.748 | 171% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 906M | 32B | 3% |
Annual Yield % from dividends | 1.55 | 2.04 | 76% |
Returns for 1 year | 2.94 | 7.09 | 41% |
Returns for 3 years | 22.91 | 29.09 | 79% |
Returns for 5 years | 49.02 | 67.46 | 73% |
Returns for 10 years | 119.22 | 101.66 | 117% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBB | 143.12 | 2.77 | +1.97% |
iShares Biotechnology ETF | |||
STK | 32.23 | 0.30 | +0.94% |
Columbia Seligman Premium Technology Growth Fund | |||
SLVR | 36.13 | 0.30 | +0.84% |
Sprott Silver Mnrs & Physical Silver ETF | |||
BCIL | 29.71 | 0.13 | +0.46% |
Bancreek International Large Cap ETF | |||
IWLG | 51.91 | -0.31 | -0.59% |
NYLI Winslow Large Cap Growth ETF |